Skip to main content

SMA: how to recognise, plus update on newly funded therapies

A floppy baby - could it have Spinal Muscular Atrophy (SMA)? With disease-modifying treatments for SMA now funded in New Zealand, early recognition and diagnosis are essential to achieve good treatment outcomes. 

In this session, Gina will cover:

  • What is SMA?
  • How common is it?
  • Diagnosis of SMA
  • Referral pathways
  • Management 
  • Update on disease-modifying therapy now funded in New Zealand.



Gina O’Grady

Paediatric Neurologist

Gina is a Paediatric Neurologist at Starship Children’s Hospital. She has a subspeciality interest in paediatric neuromuscular disease and genetic diagnosis.  

She runs a neuromuscular management clinic at Starship Children’s Hospital and has led the rollout of disease-modifying therapy for the treatment of Spinal Muscular Atrophy (SMA) in New Zealand.